Kurt Kroenke, MD, MACP
Professor of Medicine, Indiana University School of Medicine
Research Scientist, Indiana University Center for Health Services and Outcomes Research
Research Scientist, William M. Tierney Center for Health Services Research, Regenstrief Institute, Inc.
Director of Education and Training Programs, Regenstrief Institute, Inc.
Core Investigator, VA HSR&D Center for Health Information and Communication
Dr. Kroenke is Professor of Medicine in the Indiana University School of Medicine and Director of the Career Development, Education and Research Training (CERT) program for the Indiana Clinical and Translational Sciences Institute (CTSI). As part of CERT, he directs the Master of Sciences in Clinical Research and the KL2 Young Investigator programs. As a senior research scientist, he pursues his principal research interests in physical and psychological symptoms, including pain, depression, anxiety and somatization across several platforms, including the VA HSR&D Center for Health Information and Communication, and Regenstrief Institute's William M. Tierney Center for Health Services Research.
Dr. Kroenke is a past as well as current recipient of both NIH and VA HSR&D investigator-initiated grants funding randomized trials to improve the care of patients with pain, depression, and anxiety conditions. He has developed multiple patient-reported outcome measures which have been translated into 80 or more languages and used globally, including PHQ-9 depression scale, GAD-7 anxiety scale, PHQ-15 somatization scale, PEG pain scale, and P4 suicidality screener. The PHQ-9 and GAD-7 are now used by CMS, VA, FDA, national guidelines, in electronic health records, and scores of research and clinical practice settings.
Dr. Kroenke is appointed to the Psychological Health Subcommittee, Health Board, at the U. S. Department of Defense and the Science Advisory Committee to the Canadian Minister of Veterans Affairs. He serves on editorial boards for JAMA–Internal Medicine, General Hospital Psychiatry, Psychosomotic Medicine, and Psychosomatics., In 2012, Dr. Kroenke was named Distinguished Educator by the Association of Clinical Research Training (ACRT). He has mentored over thirty-five fellows and junior faculty and has more than 300 peer-reviewed research publications.
I. NIH (2013-2018)
Indiana CTSI Education/Training/Career Medicine Component (PI)
II. PCORI (2015-2017)
"Incorporating PROMIS Symptom Measures into Primary Care Practice" (PI)
III. NIH (2012-2017)
"COllaboration to Preserve PEformance in Late Stage Cancer (COPE)" (PI)
IV. VA HSR&D IIR (2013-2017)
"Comprehensive vs. Assisted Management of Mood and Pain Symptoms (CAMMPS) Trial" (PI)
|Selected Publications|||||Go To PubMed List >>|
1: Adams RN, Mosher CE, Rand KL, Hirsh AT, Monahan PO, Abonour R, Kroenke K. The Cancer Loneliness Scale and Cancer-related Negative Social Expectations Scale: development and validation. Qual Life Res. 2017 Jul;26(7):1901-1913. doi:10.1007/s11136-017-1518-4. Epub 2017 Feb 24. PubMed PMID: 28236266; PubMed Central PMCID: PMC5479729.
2: Kroenke K, Cheville A. Management of Chronic Pain in the Aftermath of the Opioid Backlash. JAMA. 2017 Jun 20;317(23):2365-2366. doi:10.1001/jama.2017.4884. PubMed PMID: 28494058.
3: Kroenke K, Unutzer J. Closing the False Divide: Sustainable Approaches to Integrating Mental Health Services into Primary Care. J Gen Intern Med. 2017Apr;32(4):404-410. doi: 10.1007/s11606-016-3967-9. Epub 2017 Feb 27. PubMed PMID:28243873; PubMed Central PMCID: PMC5377893.
4: Martin-Subero M, Kroenke K, Diez-Quevedo C, Rangil T, de Antonio M, Morillas RM, Lorán ME, Mateu C, Lupon J, Planas R, Navarro R. Depression as Measured by PHQ-9 Versus Clinical Diagnosis as an Independent Predictor of Long-Term Mortality in a Prospective Cohort of Medical Inpatients. Psychosom Med. 2017Apr;79(3):273-282. doi: 10.1097/PSY.0000000000000390. PubMed PMID: 27606795.
5: Kroenke K. When and How to Treat Subthreshold Depression. JAMA. 2017 Feb21;317(7):702-704. doi: 10.1001/jama.2017.0233. PubMed PMID: 28241337.
6: Quinn PD, Hur K, Chang Z, Krebs EE, Bair MJ, Scott EL, Rickert ME, Gibbons RD, Kroenke K, D?Onofrio BM. Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims. Pain. 2017 Jan;158(1):140-148. PubMed PMID: 27984526; PubMed Central PMCID: PMC5171228.
7: Kroenke K. Somatic symptoms deserve our attention. Fam Syst Health. 2016 Dec;34(4):330-333. PubMed PMID: 27977289.
8: Johns SA, Brown LF, Beck-Coon K, Talib TL, Monahan PO, Giesler RB, Tong Y, Wilhelm L, Carpenter JS, Von Ah D, Wagner CD, de Groot M, Schmidt K, Monceski D, Danh M, Alyea JM, Miller KD, Kroenke K. Randomized controlled pilot trial ofmindfulness-based stress reduction compared to psychoeducational support for persistently fatigued breast and colorectal cancer survivors. Support Care Cancer. 2016 Oct;24(10):4085-96. doi: 10.1007/s00520-016-3220-4. Epub 2016 May17. PubMed PMID: 27189614; PubMed Central PMCID: PMC5221754.
9: Guilkey RE, Draucker CB, Wu J, Yu Z, Kroenke K. Acceptability of a telecare intervention for persistent musculoskeletal pain. J Telemed Telecare. 2016 Sep27. pii: 1357633X16670815. [Epub ahead of print] PubMed PMID: 27681227.
10: Kroenke K, Cheville AL. Symptom Improvement Requires More Than Screening and Feedback. J Clin Oncol. 2016 Sep 20;34(27):3351-2. doi: 10.1200/JCO.2016.67.7708. Epub 2016 Jul 18. PubMed PMID: 27432929.